CA3089781A1 - Use of colchicine to inhibit tumor growth and metastases - Google Patents

Use of colchicine to inhibit tumor growth and metastases Download PDF

Info

Publication number
CA3089781A1
CA3089781A1 CA3089781A CA3089781A CA3089781A1 CA 3089781 A1 CA3089781 A1 CA 3089781A1 CA 3089781 A CA3089781 A CA 3089781A CA 3089781 A CA3089781 A CA 3089781A CA 3089781 A1 CA3089781 A1 CA 3089781A1
Authority
CA
Canada
Prior art keywords
cancer
colchicine
release
tumor
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3089781A
Other languages
English (en)
French (fr)
Inventor
Michael Riel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murray and Poole Enterprises Ltd
Original Assignee
Murray and Poole Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Murray and Poole Enterprises Ltd filed Critical Murray and Poole Enterprises Ltd
Publication of CA3089781A1 publication Critical patent/CA3089781A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3089781A 2018-02-02 2019-02-01 Use of colchicine to inhibit tumor growth and metastases Pending CA3089781A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862625354P 2018-02-02 2018-02-02
US62/625,354 2018-02-02
PCT/EP2019/052492 WO2019149884A1 (en) 2018-02-02 2019-02-01 Use of colchicine to inhibit tumor growth and metastases

Publications (1)

Publication Number Publication Date
CA3089781A1 true CA3089781A1 (en) 2019-08-08

Family

ID=65278359

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3089781A Pending CA3089781A1 (en) 2018-02-02 2019-02-01 Use of colchicine to inhibit tumor growth and metastases

Country Status (7)

Country Link
US (3) US11534415B2 (enExample)
EP (1) EP3746061A1 (enExample)
JP (3) JP2022514997A (enExample)
CN (1) CN111954524A (enExample)
CA (1) CA3089781A1 (enExample)
EA (1) EA202091736A1 (enExample)
WO (1) WO2019149884A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021089715A1 (en) * 2019-11-06 2021-05-14 Murray And Poole Enterprises, Ltd. Use of colchicine in the treatment and prevention of lung cancer
CN115068483B (zh) * 2021-03-16 2023-10-31 中国科学院上海药物研究所 Mln4924在缓解秋水仙碱中毒中的新用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
CA2286477A1 (en) 1997-04-11 1998-10-22 Dendreon Corporation Composition and method for inducing an immune response against tumour-related antigens
CN1748671A (zh) * 2005-08-30 2006-03-22 孔庆忠 含抗有丝分裂药物的缓释注射剂
CN101485637B (zh) * 2008-01-18 2011-03-30 普尔药物科技开发（深圳）有限公司 秋水仙碱骨架控释片或胶囊
ES2900740T3 (es) 2012-11-02 2022-03-18 Murray & Poole Entpr Ltd Tratamiento o prevención de episodios cardiovasculares mediante la administración de colchicina
WO2014170755A2 (en) * 2013-04-16 2014-10-23 Murray And Poole Enterprises Limited Sustained-release formulations of colchicine and methods of using same
JP2016540042A (ja) 2013-11-05 2016-12-22 コグネート バイオサービシズ， インコーポレイテッド がんを処置するためのチェックポイント阻害剤および治療薬の組合せ

Also Published As

Publication number Publication date
US20210046024A1 (en) 2021-02-18
US20240099999A1 (en) 2024-03-28
JP2022514997A (ja) 2022-02-17
EA202091736A1 (ru) 2020-10-19
US11534415B2 (en) 2022-12-27
WO2019149884A1 (en) 2019-08-08
CN111954524A (zh) 2020-11-17
JP2024050581A (ja) 2024-04-10
EP3746061A1 (en) 2020-12-09
US11877991B2 (en) 2024-01-23
US20230137776A1 (en) 2023-05-04
JP2025134752A (ja) 2025-09-17

Similar Documents

Publication Publication Date Title
US20230414521A1 (en) Sustained-release formulations of colchicine and methods of using same
US20240099999A1 (en) Use of colchicine to inhibit tumor growth and metastases
CN111278433A (zh) 尼拉帕尼制剂
WO2021089715A1 (en) Use of colchicine in the treatment and prevention of lung cancer
EA045002B1 (ru) Применение колхицина для ингибирования роста опухоли и метастазов
JP6887043B2 (ja) コルヒチンの徐放性製剤およびその使用方法
US20250152527A1 (en) Therapeutic combinations of colchicine and methods of using same
US12064507B2 (en) Composition and method for oral treatment of leukemia
US20230058726A1 (en) Chemoprevention using controlled- release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
US20230092005A1 (en) Compositions and methods for treating cancer and tumor
JP2025525297A (ja) Ｒａｓ阻害剤としてのミトキサントロン誘導体
US20210361582A1 (en) Colchicine salicylate derivatives and methods of treatment
CN115955969A (zh) 用于口服治疗白血病的组合物和方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240125